WPWM
ABMD

Western Pacific Wealth Management’s Abiomed Inc ABMD Stock Holding History

Western Pacific Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-189
Closed -$46K – 300
2022
Q3 		$46K Buy
189
+184
+3,680% +$49.7K 0.05% 105
2022
Q2 		$1K Hold
5
– – ﹤0.01% 191
2022
Q1 		$1K Hold
5
– – ﹤0.01% 219
2021
Q4 		$1K Buy
+5
New +$1.69K ﹤0.01% 223

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Western Pacific Wealth Management's ABMD Position: Q4 2022 in Review

Western Pacific Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 189 shares — an estimated $46K sold.

Western Pacific Wealth Management first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $46K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Western Pacific Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Western Pacific Wealth Management sold 189 Abiomed Inc shares in Q4 2022, an estimated $46K.
  • Western Pacific Wealth Management first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
  • Western Pacific Wealth Management's Abiomed Inc position peaked at $46K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Western Pacific Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.